Imaging Techniques in CT: Technical Development
2 other identifiers
observational
109
1 country
1
Brief Summary
Background: \- Computed tomography (CT) scanning is a procedure that helps doctors with diagnoses. It uses X-ray radiation to produce an image in three dimensions. Researchers want to study how to get the best quality CT scans using the lowest possible radiation dose. Objective: \- To determine how to improve CT scanning. Eligibility: \- Adults 45 years of age and older who have not had a CT scan in the past year and do not have kidney disease. Design:
- Participants will be screened with a medical history and blood and urine tests.
- Nurses will put an intravenous (IV) line into an arm or hand vein. It will stay in for several hours during the magnetic resonance imaging (MRI) and CT scans. Through this IV, blood will be taken, dye will be injected, and medicine will be given.
- Participants may have a CT scan of the heart, head, chest, abdomen, and/or pelvis. Participants will lie on their back on a table. The table will slide into a donut-shaped machine. An X-ray tube will move around the body, taking pictures.
- Participants may be given a drug called a beta blocker by mouth or through the IV tube.
- Participants heart rate and blood pressure will be monitored.
- Participants may have an MRI scan. The MRI is a large hollow tube. The participant will lie on a table that will be moved into the tube, which contains a magnetic field. When the imaging starts, a thumping sound will be heard. Headphones or earplugs will be provided to muffle the sound.
- Participants will give blood samples.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2014
CompletedStudy Start
First participant enrolled
July 31, 2014
CompletedFirst Posted
Study publicly available on registry
September 17, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2019
CompletedDecember 4, 2019
October 30, 2019
5.3 years
July 31, 2014
December 3, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To enhance imaging quality and safety
ongoing
Eligibility Criteria
You may qualify if:
- For new or healthy volunteers currently participating in an NIH trial: no CT scan in the last year OR For patients enrolled in a treatment or interventional trial at the NIH: no CT scan in the last 6 months
- Lab Eligibility parameters:
- For CT and MRI contrast enhanced scans:
- eGFR greater than or equal to 60 mL/min/1.73m(2) within 7 days prior to scanning
- For female participants ages 45-60 within 3 days prior to scan (unless post-menopausal or no longer able to bear children, note exemption on initial visit):
- Pregnancy test result(blood or urine): Negative
- Willing to travel to the NIH for follow-up visits.
- Greater than or equal to 45 years old
- Able to understand and sign informed consent
- Stable clinical status
- Volunteer indicates no history of participation in NIH protocols using research radiation in the last 12 months (e.g. PET research scans, NCI Molecular Imaging Center PET scans, etc)
You may not qualify if:
- Prior CT scan in the last 12 months for new volunteers or healthy volunteers enrolled in NIH trials OR Prior CT scan in the last 6 months for patients enrolled in a treatment or interventional trial
- Pregnant women
- Over 500 lbs and/or a body circumference that prevents the study subject from lying flat in the scanner
- Claustrophobia requiring sedation or anesthesia.
- Known or suspected genetic predisposition to cancer
- Any contraindications that the research team identifies from the subject, radiology department CT and/or MRI questionnaires, and/or History and Assessment.
- Allergy to iodinated contrast for scans (study subject will be eligible for non-contrast scans)
- Acute renal failure, renal transplant, dialysis and renal failure (clinically diagnosed).\<TAB\>
- Lactating women
- Patient preference to not undergo intravenous line placement and/or receive iodinated contrast. Contrast administration is optional and participants may still undergo a non-contrast study.
- Use of metformin-containing products less than 24 hours prior To CT contrast administration
- Other contraindications to iodinated contrast media as determined by the research team.
- Allergy to gadolinium for scans using contrast; will be eligible for non-contrast scans.
- Acute renal failure, renal transplant, dialysis and renal failure individuals ( Lab Eligibility parameters and/or clinically diagnosed).\<TAB\>
- Lactating women
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Related Publications (3)
Halliburton S, Arbab-Zadeh A, Dey D, Einstein AJ, Gentry R, George RT, Gerber T, Mahesh M, Weigold WG. State-of-the-art in CT hardware and scan modes for cardiovascular CT. J Cardiovasc Comput Tomogr. 2012 May-Jun;6(3):154-63. doi: 10.1016/j.jcct.2012.04.005. Epub 2012 Apr 7.
PMID: 22551595BACKGROUNDTrattner S, Pearson GDN, Chin C, Cody DD, Gupta R, Hess CP, Kalra MK, Kofler JM Jr, Krishnam MS, Einstein AJ. Standardization and optimization of CT protocols to achieve low dose. J Am Coll Radiol. 2014 Mar;11(3):271-278. doi: 10.1016/j.jacr.2013.10.016.
PMID: 24589403BACKGROUNDMahesh M. Variability in CT protocols. J Am Coll Radiol. 2013 Oct;10(10):805-6. doi: 10.1016/j.jacr.2013.07.005. Epub 2013 Aug 26. No abstract available.
PMID: 23988585BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
David A Bluemke, M.D.
National Institutes of Health Clinical Center (CC)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2014
First Posted
September 17, 2014
Study Start
July 31, 2014
Primary Completion
October 30, 2019
Study Completion
October 30, 2019
Last Updated
December 4, 2019
Record last verified: 2019-10-30